Q3 2025 Pharming Group NV Earnings Call Transcript
Key Points
- Pharming Group (PHGUF) reported a 30% increase in total revenues for Q3 2025 compared to the same quarter last year.
- Operating profit surged to $15.8 million, nearly four times the previous year's results.
- RUCONEST and Joenja, the company's two commercial assets, showed significant growth, with RUCONEST growing 29% year-on-year.
- The company raised its full-year 2025 revenue guidance to $365 to $375 million, up from the previous $335 to $350 million.
- Pharming Group (PHGUF) is advancing its pipeline with two programs having over $1 billion sales potential each, indicating strong future growth prospects.
- The company plans to delist RUCONEST in some European countries due to financial unsustainability, which may impact its presence in those markets.
- There is ongoing competition in the HAE market, although RUCONEST serves a distinct patient population.
- The company faces challenges in expanding Joenja's market, needing to ensure reimbursement at the right price in new markets.
- Pharming Group (PHGUF) is undergoing a significant reduction in G&A headcounts, which could impact employee morale and operations.
- The reclassification of VUS patients as APDS is progressing slower than anticipated, potentially delaying expected growth from this segment.
Good day and thank you for standing by. Welcome to Farming Group and the 3rd quarter 2025 results conference call and webcast. At this time all participants on a lesson only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you'll need to press one and one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press one and one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Fabrice Chouraqui, Chief Executive Officer. Please go ahead.
Thank you, operator, and good morning and good afternoon, everyone and welcome to the Farming's Q3 2025 earning calls. I'll be joined on this call today by Stephen Toor, our Chief Commercial Officer, Anurag Relan, our Chief Medical Officer, and Kenneth Lynard, our new Chief Financial Officer. On this call, we will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
